Lv1
36 积分 2025-11-13 加入
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
2天前
已完结
Clinical Trial: Plozasiran Prevents Recurrent Pancreatitis in Adults With Very Severe Hypertriglyceridemia-Results of a Post Hoc Analysis of the Phase 3 PALISADE Study
2天前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2天前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2天前
已完结
Approach to the Patient: Clinical Outcomes and Interim Strategies Following Discontinuation of Incretin Agonists
2天前
已完结
Weight regain after cessation of medication for weight management: systematic review and meta-analysis
2天前
已完结
Endocrine Manifestations and New Developments in Mitochondrial Disease
1个月前
已完结
Rare but Serious: Ibrutinib Induced Liver Failure
2个月前
已完结
Diabetic ketoacidosis with SGLT2 inhibitors
2个月前
已完结
Outcomes of low-dose trimethoprim-sulfamethoxazole treatment in patients with non-HIV pneumocystis pneumonia: A nationwide Japanese retrospective cohort study
3个月前
已关闭
皖公网安备34019202002308
